Geron GERN
NASDAQ GERN
$1.12 -0.04 (-3.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Geron (GERN) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Geron (GERN) posted Return on Capital Employed [ROCE] of -11.35% for Q2 2026, up 4.31 percentage points from -15.66% a year earlier but down 0.54 percentage points from the prior quarter.

Analysis

Geron (GERN) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Geron's Return on Capital Employed [ROCE] came in at -14.57%, up 28.26 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +26.52 percentage points (FY2020 to FY2025).
  • In prior years, Geron's Return on Capital Employed [ROCE] was -42.83% in FY2024 (+62.43 pp), -105.26% in FY2023 (+0.01 pp), -105.27% in FY2022 (-49.08 pp) and -56.20% in FY2021 (-15.11 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -102.71% in Q4 2022 to a high of -10.80% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last seven quarters, with an average year-over-year change of +25.07 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2025, with a gain of 53.93 percentage points; the weakest was Q4 2022, with a drop of 40.09 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -10.80% (Q1 2026), -14.99% (Q4 2025) and -13.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Geron 719.57 Mn -632.13 Mn - -11.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.35%
Mar 31, 2026 -10.80%
Dec 31, 2025 -14.99%
Sep 30, 2025 -13.32%
Jun 30, 2025 -15.66%
Mar 31, 2025 -26.07%
Dec 31, 2024 -40.30%
Sep 30, 2024 -67.25%
Jun 30, 2024 -62.77%
Mar 31, 2024 -66.68%
Dec 31, 2023 -65.64%
Sep 30, 2023 -55.92%
Jun 30, 2023 -50.05%
Mar 31, 2023 -56.85%
Dec 31, 2022 -102.71%
Sep 30, 2022 -83.62%
Jun 30, 2022 -66.10%
Mar 31, 2022 -68.97%
Dec 31, 2021 -62.62%
Sep 30, 2021 -52.57%
API Access

Geron Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GERN&period=max&api_key=YOUR_API_KEY